Mader Group Limited (MADGF)

Ligand Pharmaceuticals Revenue

Mader Group had revenue of 411.50M AUD in the half year ending December 31, 2024, with 46.78% growth. This brings the company's revenue in the last twelve months to 811.54M, up 15.46% year-over-year. In the fiscal year ending June 30, 2024, Mader Group had annual revenue of 774.47M with 27.21% growth.

• Revenue (ttm): 811.54M AUD
• Revenue Growth: +15.46%
• P/S Ratio: 1.87
• Revenue / Employee: 253.61K AUD
• Employees: 3,200
• Market Cap: 939.99M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	774.47M	165.68M	27.21%
Jun 30, 2023	608.79M	206.71M	51.41%
Jun 30, 2022	402.08M	97.78M	32.13%
Jun 30, 2021	304.30M	30.75M	11.24%
Jun 30, 2020	273.55M	44.90M	19.64%